MedTrace Logo

Maternal Antibody in Milk After Vaccination

NCT03982732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2019-06-11

No results posted yet for this study

Summary

Single-centre observational pilot study exploring pertussis specific antibody concentration in the breastmilk of women vaccinated against pertussis in pregnancy at different gestational ages. This study is made up of two stages: first stage to confirm recruitment methods and optimise the laboratory assay and a second stage to complete recruitment for the pilot study.

Conditions

  • Pertussis
  • Vaccination
  • Pregnancy
  • Breastmilk

Interventions

BIOLOGICAL

Boostrix-IPV

Receipt of Boostrix IPV at three different gestational time periods

Sponsors & Collaborators

  • European Society for Paediatric Infectious Diseases

    collaborator OTHER

  • St George's, University of London

    lead OTHER

Principal Investigators

  • Kirsty Le Doare · St George's, Univeristy of London

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-07
Primary Completion
2019-08-31
Completion
2019-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03982732 on ClinicalTrials.gov